aterosklerozАтеросклерозAteroscleroz2078-256X2949-3633НИИТПМ-филиал ИЦиГ СО РАН10.52727/2078-256X-2023-19-2-145-153ateroskleroz-909Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSСостояние миокарда после коронарной реваскуляризации у лиц с избыточной массой телаMyocardial state in overweight individuals after coronary revascularizationhttps://orcid.org/0000-0003-4501-2454СейтековаА. Н.SeytekovaA. N.

Айжан Нурлановна Сейтекова, докторант 3-го года обучения по специальности «Медицина»

г. Караганда, ул. Гоголя, 40

 

40, Gogol str., Karaganda

Aizhan_ai@mail.ruhttps://orcid.org/0000-0001-8473-4375Молотов-ЛучанскийВ. Б.Molotov-LuchanskiyV. B.

Вилен Борисович Молотов-Лучанский, д-р мед. наук, проф.

г. Караганда, ул. Гоголя, 40

Aizhan N. Seytekova, doctoral student of the 3rd year of study in the specialty «Medicine»

40, Gogol str., Karaganda

Molotov-luchanskiy@qmu.kzНАО «Медицинский университет Караганды»Medical University of Karaganda202311072023192145153Copyright © Сейтекова А.Н., Молотов-Лучанский В.Б., 20232023Сейтекова А.Н., Молотов-Лучанский В.Б.Seytekova A.N., Molotov-Luchanskiy V.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ateroskleroz.elpub.ru/jour/article/view/909

Болезни сердца и сосудов, или сердечно-сосудистые заболевания (ССЗ), сохраняют свою актуальность на протяжении многих десятилетий и остаются наиболее серьезной проблемой здравоохранения во многих странах мира. Эксперты ВОЗ прогнозируют, что к 2030 г. смерть от ССЗ может наступить у 23,6 млн человек трудоспособного возраста. Широкое применение реконструктивных и интервенционных вмешательств, обеспечивающих восстановление кровотока в миокарде, позволило добиться прогресса в лечении ССЗ. Вместе с тем у пациентов сохраняются серьезные проблемы в реперфузионный период на различных этапах реабилитации.

Heart and vascular diseases, or cardiovascular diseases (CVDs), have remained relevant for many decades and remain the most serious health problem in many countries around the world, including Kazakhstan. Experts from the World Health Organization (WHO) predict that by 2030 death from CVD may occur in 23.6 million people of working age. The widespread use of reconstructive and interventional methods, ensuring the restoration of blood flow in the myocardium, has made progress in the treatment of cardiovascular diseases. At the same time, serious problems remain during the reperfusion period at various stages of rehabilitation. The purpose of the review was to analyze the results of studies on the state of the myocardium in overweight individuals, especially after undergoing coronary artery surgery. The depth of the sample of literary sources was 20 years.

сердечно-сосудистые заболеванияизбыточная масса телареперфузия миокардаэхокардиографияcardiovascular diseaseoverweightmyocardial reperfusionechocardiographyReferencesЭлектронный ресурс. https://www.who.int/ru/newsroom/fact-sheets/detail/the-top-10-causes-of-deathElectronic resource. https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causesof-death (In Russ.)Шпагина О.В., Бондаренко И.З. «Парадокс ожирения» – еще один взгляд на проблему сердечно-сосудистых заболеваний. Обзор литературы. Ожирение и метаболизм, 2016; (4): 4–9.Shpagina O.V., Bondarenko I.Z. The «Obesity Par adox» is another look at the problem of cardiovas cular diseases. Literature review. Obesity and Metabolism, 2016; (4): 4–9. (In Russ.)Бердыгалиев А.Б., Чуенбекова А.Б., Кайнарбаева М.С., Быкыбаева С.А., Сержантова Г.Н., Аскаров Д.М. Изучение распространенности избыточной массы тела и ожирения среди женщин в Казахстане. Вестн. КазНМУ, 2015; (1): 409–413.Berdygaliev A.B., Chuenbekova A.B., Kaynarbayeva M.S., Bykybayeva S.A., Sergeantova G.N., Askarov D.M. Studying the prevalence of overweight and obesity among women in Kazakhstan. Bulletin of KazNMU, 2015; (1): 409–413. (In Russ.)Электронный ресурс. https://www.who.int/europe/ru/news/item/03-05-2022-obesity-causes-cancer-andis-major-determinant-of-disability-and-death--warnsnew-who-reportElectronic resource. https://www.who.int/europe/ru/news/item/03-05-2022-obesity-causes-cancer-and-is-major-determinant-of-disability-and-death--warns-new-who-report(In Russ.)Разина А.О., Руненко С.Д., Ачкасов Е.Е. Проблема ожирения: современные тенденции в России и в мире. Вестн. РАМН, 2016; 71 (2): 154–159. doi: 10.15690/vramn655Razina A.O., Runenko S.D., Achkasov E.E. The problem of obesity: current trends in Russia and in the world. Bull. of the Russian Academy of Medical Sciences, 2016; 71 (2): 154–159 (In Russ.)Бардымова Т.П., Михалева О.Г., Березина М.В. Современный взгляд на проблему ожирения. Бюл. ВСНЦ СО РАМН, 2011; 81: 5.Bardymova T.P., Mikhaleva O.G. Berezina M.V. A modern view on the problem of obesity. Bulletin of the All-Russian Scientific Research Center of the Russian Academy of Medical Sciences, 2011; 81: 5. (In Russ.)Разина А.О., Ачкасов Е.Е. Ожирение: современный взгляд на проблему. Ожирение и метаболизм, 2016; 13 (1): 3–8.Razina A.O., Achkasov E.E. Obesity: a modern view of the problem. Obesity and Metabolism, 2016; 13 (1): 3–8. (In Russ.)Колосницына М.Г., Куликова О.А. Социально-экономические факторы и последствия избыточного веса. Демографическое обозрение, 2018; 5 (4): 92–124.Kolosnitsyna M.G., Kulikova O.A. Socio-economic factors and consequences of overweight. Demographic Review, 2018; 5 (4): 92–124. (In Russ.)Rachel Harrison. «Obesity paradox» not found measu ring new cases if cardiovascular disease. J. LOS ONE, 2017; (12): 14–16.Rachel Harrison. «Obesity paradox» not found measu ring new cases if cardiovascular disease. J. LOS ONE, 2017; (12): 14–16.Всемирный атлас профилактики сердечно-сосудистых заболеваний и борьбы с ними. Под ред.: S. Mendis, P. Puska, B. Norrving. Всемирный атлас профилактики сердечно-сосудистых заболеваний и борьбы с ними. Всемирная организация здравоохранения. Женева, 2013.Mendis S., Puska P., Norrving B. World Atlas of Prevention and Control of Cardiovascular Diseases. World Health Organization. Geneva, 2013. (In Russ.)Antonopoulos А., Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovascular. Res., 2017; 113: 1074–1086. doi: 10.1093/cvr/cvx106Antonopoulos А., Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovascular. Res., 2017; 113: 1074–1086. doi: 10.1093/cvr/cvx106Sharma A., Vallakati А., Einstein A.J. Relationship of Body Mass Index with Total Mortality, Cardiovascular Mortality, and Myocardial Infarction After Coronary Revascularization. Evidence from a Metaanalysis. Mayo Clin. Proc., 2014; 89 (8): 1080–1100. doi: 10.1016/j.mayocp.2014.04.020Sharma A., Vallakati А., Einstein A.J. Relationship of Body Mass Index with Total Mortality, Cardiovascular Mortality, and Myocardial Infarction After Coronary Revascularization. Evidence from a Metaanalysis. Mayo Clin. Proc., 2014; 89 (8): 1080–1100. doi: 10.1016/j.mayocp.2014.04.020Barth S., Zacher В., Reinecke Н. Decreasing incidence of coronary heart disease in extreme obesity (BMI ? 40). A single centre experience. Obes. Res. Clin. Pract., 2017; 11 (4): 435–444. doi: 10.1016/j.orcp.2016.08.007Barth S., Zacher В., Reinecke Н. Decreasing incidence of coronary heart disease in extreme obesity (BMI ? 40). A single centre experience. Obes. Res. Clin. Pract., 2017; 11 (4): 435–444. doi: 10.1016/j.orcp.2016.08.007Драпкина О.М., Корнеева О.М., Палаткина Л.О. Дипокины и сердечно-сосудистые заболевания: патогенетические параллели и терапевтические параллели. Артериальная гипертензия, 2011; 3 (17): 202–211.Drapkina O.M., Korneeva O.M., Palatkina L.O. Adipokines and cardiovascular diseases: pathogenetic parallels and therapeutic parallels. Arterial Hypertension, 2011; 17 (3): 202–211. (In Russ.)Дашутина С.Ю., Перетолчина С.Ю., Барац С.С., Серебренников В.А. Типы структурно-геометрического ремоделирования левого желудочка и анализ систоло-диастолических показателей внутрисердечной гемодинамики при изолированном ожирении. Рос. кардиол. журн., 2005; (4): 42–46.Dashutina S.Yu., Peretolchina S.Yu., Barats S.S., Serebrennikov V.A. Structural and geometric left ventricular remodeling and systolo-diastolic parameters of intracardiac hemodynamics in isolated obesity. Rus. J. Cardiol., 2005; (4): 42–46. (In Russ.)Постоева А.В., Дворяшина И.В., Бахтина З.Э., Елисеева И.В. Анализ предикторов гипертрофии левого желудочка у женщин с ожирением различной выраженности. Ожирение и метаболизм, 2015; 12 (4): 34–41. https://doi.org/10.14341/omet2015434-41Postoeva A.V., Dvoryashina I.V., Bakhtina Z.E., Eliseeva I.V. Analysis of left ventricular hypertrophy predictors in women with different levels of obesity. Obesity and Metabolism, 2015; 12 (4): 34–41. (In Russ.)Rashid M.A., Qureshi B.A., Ahmed N., Sherwani M.A. Impact of body mass index on left ventricular mass. J. Ayub Med. College, 2017; 26 (2): 167–169.Rashid M.A., Qureshi B.A., Ahmed N., Sherwani M.A. Impact of body mass index on left ventricular mass. J. Ayub Med. College, 2017; 26 (2): 167–169.Миклишанская С.В., Мазур Н.А., Соломасова Л.В., Чигинева В.В. «Парадокс ожирения» и степень его доказанности. Терапевт. арх., 2020; 92 (4): 84–90. doi: 10.26442/00403660.2020.04.000421Miklishanskaya S.V., Mazur N.A., Solomasova L.V., Chigineva V.V. «The obesity paradox» and the degree of its proof. Therapeutic Archive, 2020; 92 (4): 84–90. (In Russ.)Naganuma T., Chieffo А., Meliga Е. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc. Interv., 2014; 7: 354–361.Naganuma T., Chieffo А., Meliga Е. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc. Interv., 2014; 7: 354–361.Qin Q., Qian J., Wu X. et al. A comparison between coronary artery bypass grafting surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease. Clin. Cardiol., 2013; 36: 54–60.Qin Q., Qian J., Wu X. et al. A comparison between coronary artery bypass grafting surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease. Clin. Cardiol., 2013; 36: 54–60.Serruys P.W., Ong A.T., van Herweden L.A. Five – year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease the final analysis of the arterial revascularization therapies study (ARTS). Randomized trial. J. Am. Coll. Cardiol., 2005; 46 (4): 575–581.Serruys P.W., Ong A.T., van Herweden L.A. Five – year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease the final analysis of the arterial revascularization therapies study (ARTS). Randomized trial. J. Am. Coll. Cardiol., 2005; 46 (4): 575–581.Califf R.M. Stenting or surgery. An opportunity to do it right. J. Am. Coll. Cardiol., 2005; 46: 589–591.Califf R.M. Stenting or surgery. An opportunity to do it right. J. Am. Coll. Cardiol., 2005; 46: 589–591.O’Neil W.W., Grines C.L. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the stent or surgery trial): a randomized controlled trial. Lancet, 2002; 360: 956–970.O’Neil W.W., Grines C.L. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the stent or surgery trial): a randomized controlled trial. Lancet, 2002; 360: 956–970.Rodriguez A.E., Baldi J., Pereira C.F. Five-year follow – up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessels disease (ERACI II). J. Am. Coll. Cardiol., 2005; 46: 582–598.Rodriguez A.E., Baldi J., Pereira C.F. Five-year follow – up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessels disease (ERACI II). J. Am. Coll. Cardiol., 2005; 46: 582–598.Rodriguez A.E., Bernardy V., Navia J. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessels disease (ERACI II): 30-day and one – year follow-up results. ERACI II Investigators. J. Am. Coll. Cardiol., 2001; 37: 51–58.Rodriguez A.E., Bernardy V., Navia J. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessels disease (ERACI II): 30-day and one – year follow-up results. ERACI II Investigators. J. Am. Coll. Cardiol., 2001; 37: 51–58.Fergusson T.B.Jr., Hammfill B.G., Peterson E.D. A decade of change – risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from theSTS National Database-Commityandthe Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann. Thorac. Surg., 2002; 73: 480–489.Fergusson T.B.Jr., Hammfill B.G., Peterson E.D. A decade of change – risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from theSTS National Database-Commityandthe Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann. Thorac. Surg., 2002; 73: 480–489.Hueb W., Soares P.R., Gersh B.J. The medicine, angioplasty, or surgery study (MASS-II): a randomizedcontrolledclinical trial ofthreetherapeutic stagesfor multivessel coronary artery disease. J. Am. Coll. Cardiol., 2004; 43: 1743–1751.Hueb W., Soares P.R., Gersh B.J. The medicine, angioplasty, or surgery study (MASS-II): a randomizedcontrolledclinical trial ofthreetherapeutic stagesfor multivessel coronary artery disease. J. Am. Coll. Cardiol., 2004; 43: 1743–1751.Raimondo Ascione, Barnaby C. Reeves, Karen Rees. Gianni D. Angelini. Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients. Circulation, 2002; 106: 1764–1770.Raimondo Ascione, Barnaby C. Reeves, Karen Rees. Gianni D. Angelini. Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients. Circulation, 2002; 106: 1764–1770.Aronov D., Bubnova M., Iosseliani D., Orekhov A. Clinical Efficacy of а Medical Centre- and Home-based Cardiac Rehabilitation Program for Patients with Coronary Heart Disease After Coronary Bypass Graft Surgery. Arch. Med. Res., 2019; 50 (3): 122–132.Aronov D., Bubnova M., Iosseliani D., Orekhov A. Clinical Efficacy of а Medical Centre- and Home-based Cardiac Rehabilitation Program for Patients with Coronary Heart Disease After Coronary Bypass Graft Surgery. Arch. Med. Res., 2019; 50 (3): 122–132.Чеснокова Н.П., Понукалина Е.В., Бизенкова М.Н. Молекулярно-клеточные механизмы цитотоксического действия гипоксии. Патогенез гипоксического некробиоза. Соврем. наукоемк. технологии, 2006; 7: 32–40.Chesnokova N.P., Ponukalina E.V., Bizenkova M.N. Molecular and cellular mechanisms of cytotoxic action of hypoxia. Pathogenesis of hypoxic necrobiosis. Modern. High-tech. Technol., 2006; 7: 32–40. (In Russ.)Бокерия Л.А., Чичерин И.Н. Природа и клиническое значение “новых ишемических синдромов”. М.: Изд-во НЦССХ им. А.Н. Бакулева РАМН, 2007. С. 302.Bokeria L.A., Chicherin I.N. The nature and clinical significance of “new ischemic syndromes”. M.: Publishing House of the A.N. Bakulev National Research Center of the Rus. Acad. Med. Sci., 2007. P. 302. (In Russ.)Пархоменко А.Н., Брыль Ж.В. Патофизиологические механизмы ишемического и реперфузионного повреждения миокарда в экспериментальных исследованиях. Укр. кардіол. журн., 2000; 5 (6): 95–99.Parkhomenko A.N., Bryl Zh.V. Pathophysiological mechanisms of ischemic and reperfusion myocardial injury in experimental studies. Ukrainian Cardiol. J., 2000; 5-6: 95–99. (In Russ.)Lyubimov A.V., Shabanov P.D. Ischemia, reperfusion and preconditioning: traditional and new approaches for treatment of myocardial infarction. Clin. Pharmacol. and Drug Ther. Rev., 2016; 14 (3): 3–11.Lyubimov A.V., Shabanov P.D. Ischemia, reperfusion and preconditioning: traditional and new approaches for treatment of myocardial infarction. Clin. Pharmacol. and Drug Ther. Rev., 2016; 14 (3): 3–11.Venetucci L.A., Trafford A.W., O’Neill S.C. The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc. Res., 2008; 77 (2): 285–292.Venetucci L.A., Trafford A.W., O’Neill S.C. The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc. Res., 2008; 77 (2): 285–292.Hausenloy D.J., Yellon D.M. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J. Mol. Cell. Cardiol., 2003; 35 (4): 339–341.Hausenloy D.J., Yellon D.M. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J. Mol. Cell. Cardiol., 2003; 35 (4): 339–341.Perrelli M.G., Pagliaro Р., Penna С. Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. World J. Cardiol., 2011; 3 (9): 186–200.Perrelli M.G., Pagliaro Р., Penna С. Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. World J. Cardiol., 2011; 3 (9): 186–200.Пархоменко А.Н. Феномен невосстановленного кровотока у больных с острым коронарным синдромом и возможные пути улучшения тканевой перфузии. Укр. кардіол. журн., 2007; 5: 17–25.Parkhomenko A.N. The phenomenon of unrecoverable blood flow in patients with acute coronary syndrome and possible ways to improve tissue perfusion. Ukrainian Cardiol. J., 2007; 5: 17–25. (In Russ.)Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med., 2006; 3 (9): 499–506.Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med., 2006; 3 (9): 499–506.Jaffe R., Charron Т., Puley G., Dick А., Strauss B.H. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation, 2008; 117 (24): 3152–3156.Jaffe R., Charron Т., Puley G., Dick А., Strauss B.H. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation, 2008; 117 (24): 3152–3156.Choi C.J., HajiMomenian S., Dimaria J.M. Infarct involution and improved function during healing ofacute myocardial infarction: the role of microvascular obstruction. J. Cardiovasc. Magn. Reson., 2004; 6 (4): 917–925.Choi C.J., HajiMomenian S., Dimaria J.M. Infarct involution and improved function during healing ofacute myocardial infarction: the role of microvascular obstruction. J. Cardiovasc. Magn. Reson., 2004; 6 (4): 917–925.de Waha S., Desch S., Eitel I. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after STelevation myocardial infarction: a comparison with traditional prognostic markers. Eur. Heart J., 2010; 31 (21): 2660–2668.de Waha S., Desch S., Eitel I. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after STelevation myocardial infarction: a comparison with traditional prognostic markers. Eur. Heart J., 2010; 31 (21): 2660–2668.Ягудин Т.А., Шабанова А.Т., Ишметов В.Ш., Hong-Yu. Liu. Влияние ишемического кондиционирования на сократительную функцию миокарда при ишемическом и реперфузионном повреждениях миокарда. Мед. вестн. Башкортостана, 2019; 1 (79): 86–98.Yagudin T.A., Shabanova A.T., Ishmetov V.Sh., Hong-Yu. Liu. The effect of ischemic conditioning on the contractile function of the myocardium in ischemic and reperfusion injuries of the myocardium. Med. Bull. Bashkortostan, 2019; 1 (79): 86–98.(In Russ.)Xu X.J.., Gauthier M.-S., Hess D.T. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J. Lipid. Res., 2012; 53 (4): 792–801. doi: 10.1194/jlr.P022905Xu X.J.., Gauthier M.-S., Hess D.T. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J. Lipid. Res., 2012; 53 (4): 792–801. doi: 10.1194/jlr.P022905Аrbownik-Lewinska M., Szosland J., Kokoszko-Bilska А. Direct contribution of obesity to oxidative damage to macromolecules. Neuro Endocrinol. Lett., 2012; 33 (4): 453–461.Аrbownik-Lewinska M., Szosland J., Kokoszko-Bilska А. Direct contribution of obesity to oxidative damage to macromolecules. Neuro Endocrinol. Lett., 2012; 33 (4): 453–461.Agarwal A., Aziz N., Rizk В. Studies on Women’s Health. NewYork: Humana Press, 2013. P. 33–60. doi: https://doi.org/10.1007/978-1-62703-041-0Agarwal A., Aziz N., Rizk В. Studies on Women’s Health. NewYork: Humana Press, 2013. P. 33–60. doi: https://doi.org/10.1007/978-1-62703-041-0Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obe sity-related insulin resistance. Physiol, Behav., 2008; 94 (2): 206–218. doi: 10.1016/j.physbeh.2007.10.010Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obe sity-related insulin resistance. Physiol, Behav., 2008; 94 (2): 206–218. doi: 10.1016/j.physbeh.2007.10.010Мельникова Ю.С., Макарова Т.П. Эндотелиальная дисфункция как центральное звено патогенеза хронических болезней. Казанск. мед. журн., 2015; 96 (4): 659–665.Melnikova Yu.S., Makarova T.P. Endothelial dysfunction as a central link in the pathogenesis of chronic diseases. Kazan Med. J., 2015; 96 (4): 659–665. doi: 10.17750/KMJ2015-659(In Russ.)Мамедова Ф.И. Влияние оксидативного стресса на состояние эндотелия у пациентов с сердечной недостаточностью и сахарным диабетом 2-го типа. Казанск. мед. журн., 2020; 101 (1): 13–17.Mammadova F.I. The effect of oxidative stress on the state of the endothelium in patients with heart failure and type 2 diabetes mellitus. Kazan Med. J., 2020; 101 (1): 13–17. doi: 10.17816/KMJ2020-13(In Russ.)Wenceslau C.F., McCarthy C.G., Szasz T. et al. The role of adipose tissue dysfunction in the pathogenesis of obe sity-related insulin resistance. Physiol. Behav., 2008; 94 (2): 206–218. doi: 10.1016/j.physbeh.2007.10.010Wenceslau C.F., McCarthy C.G., Szasz T. et al. The role of adipose tissue dysfunction in the pathogenesis of obe sity-related insulin resistance. Physiol. Behav., 2008; 94 (2): 206–218. doi: 10.1016/j.physbeh.2007.10.010Бадоян А.Г., Горгулько А.П., Хелимский Д.А., Крестьянинов О.В., Берген Т.А., Найденов Р.А., Баранов А.А. Роль коллатерального кровообращения в поддержании и восстановлении функции миокарда левого желудочка и современные методы его оценки. Рос. кардиол. журн., 2022; 27 (8): 5164.Badoyan A.G., Gorgulko A.P., Khelimsky D.A., Krestyaninov O.V., Bergen T.A., Naydenov R.A., Baranov A.A. Role of collateral circulation in maintaining and restoring the left ventricular function and modern methods for its assessment. Rus. J. Cardiol., 2022; 27 (8): 5164. https://doi.org/10.15829/1560-4071-2022-5164 (In Russ.)Antman E.M., Anbe D.T., Armstrong P.W. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation, 2004; 110 (9): 282–292.Antman E.M., Anbe D.T., Armstrong P.W. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation, 2004; 110 (9): 282–292.Bautin A.E., Grebenchikov О.А., Eremenko А.А. et al. Adjuvant Cardioprotection in Cardiac Patients. Moscow: OOO «RIA “FarmEtika”» Publ., 2017. Р. 226.Bautin A.E., Grebenchikov О.А., Eremenko А.А. et al. Adjuvant Cardioprotection in Cardiac Patients. Moscow: OOO «RIA “FarmEtika”» Publ., 2017. Р. 226.Аронов Д.М., Бубнова М.Г. Проблемы внедрения новой системы кардиореабилитации в России. Рос. кардиол. журн., 2013; 4: 102.(In Russ.)Aronov D.M., Bubnova M.G. Problems of introduction of a new cardiorehabilitation system in Russia. Rus. J. Cardiol., 2013; 3 (4): 102.Кардиоматика. 2016; 7: 3–4. www.con-med.ruCardio mastic. 2016; 7: 3–4. www.con-med.ru. (In Russ.)Васюк Ю.А., Школьник Е.Л. Современные возможности и ограничения эхокардиографии при заболеваниях сердечно-сосудистой системы. Рос. кардиол. журн., 2013; 4 (102): 28–32.Vasyuk Yu.A., Shkolnik E.L. Modern possibilities and limitations of echocardiography in diseases of the cardiovascular system. Rus. J. Cardiol., 2013; 4 (102): 28–32. (In Russ.)Rudski L.G., Lai W.W., Afilalo J. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults. A Report from the American Society of Echocardiography. J. Am. Soc. Echocardiogr., 2010; 23: 685–713.Rudski L.G., Lai W.W., Afilalo J. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults. A Report from the American Society of Echocardiography. J. Am. Soc. Echocardiogr., 2010; 23: 685–713.Lang R.M., Bierig М. Recommendations for chamber quantification. Eur. J. Echocardiogr., 2006; 7: 79–108.Lang R.M., Bierig М. Recommendations for chamber quantification. Eur. J. Echocardiogr., 2006; 7: 79–108.Oh J.K., Seward J.B., Tajik A.J. The Echo Manual. Third edition. Lippincott Williams & Wilkins, 2007.Oh J.K., Seward J.B., Tajik A.J. The Echo Manual. Third edition. Lippincott Williams & Wilkins, 2007.Vasyuk Y.A., Kozin А.А. et al. Features of diastolic function and remodeling of the left ventricle in patients with arterial hypertension and ischemic heart disease. J. Cardiac. Failure, 2003; 4 (4): 190–193.Vasyuk Y.A., Kozin А.А. et al. Features of diastolic function and remodeling of the left ventricle in patients with arterial hypertension and ischemic heart disease. J. Cardiac. Failure, 2003; 4 (4): 190–193.Харви Фейгенбаум. Эхокардиография; пер. с англ. под ред. В.В. Митькова. 5-е изд. Москва: Видар, 1999.Harvey Feigenbaum. Echocardiography; trans. edited by V.V. Mitkov. 5th ed. Moscow: Vidar Publ., 1999. (In Russ.)Nagueh S.F., Appleton C.P., Gillebert T.C. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur. J. Echocardiogr., 2009; 10 (2): 65–93.Nagueh S.F., Appleton C.P., Gillebert T.C. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur. J. Echocardiogr., 2009; 10 (2): 65–93.

The authors declare that there are no conflicts of interest present.